Atopic Dermatitis: Personalized Treatment Approaches

We are studying how genetic and biochemical markers can help choose the best treatment for patients with atopic dermatitis needing stronger therapies. This research may lead to better management strategies tailored to individual needs.

6-12 months 6-10 visits Monitoring phase (IV)No Placebo Standard Medicines Oral InjectionAllergologyDermatology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Adtralza

Adtralza is a medicine used to treat moderate-to-severe atopic dermatitis (eczema) in adults by helping reduce skin inflammation and itching.

Cibinqo

Cibinqo is a medicine used to treat moderate-to-severe eczema, helping reduce skin inflammation and itching.

Dupixent

Dupixent is a medicine used to treat eczema and certain asthma symptoms.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Abrocitinib

Abrocitinib is a substance that reduces inflammation and itching in people with moderate-to-severe eczema by blocking a specific immune signaling pathway.

Baricitinib

Baricitinib is a substance that reduces immune-driven inflammation to treat rheumatoid arthritis.

Dupilumab

Dupilumab is a substance that reduces allergic inflammation to treat moderate-to-severe eczema, some asthma, and nasal polyps.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Hospital Universitario La Paz

Pharmacology Service

Chamartín, Spain

Sponsor: Hospital Universitario La Paz

Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.